NeuroPace, Inc.
Price Action
Technical Summary
EMERGING TRENDNeuroPace, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 87), indicating clear outperformance against the broad market. Earnings growth of 56% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.33 | +10.95% | ABOVE |
| 50 SMA | $14.90 | +21.60% | ABOVE |
| 100 SMA | $15.38 | +17.78% | ABOVE |
| 150 SMA | $14.47 | +25.24% | ABOVE |
| 200 SMA | $13.18 | +37.45% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NPCE in an uptrend right now?
NPCE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is NPCE overbought or oversold?
NPCE's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is NPCE outperforming the market?
NPCE has a Relative Strength (RS) Rating of 87 out of 99. Yes, NPCE is a market leader, outperforming 87% of all stocks over the past 12 months.
Where is NPCE in its 52-week range?
NPCE is trading at $18.12, which is 95% of its 52-week high ($18.98) and 92% above its 52-week low ($7.56).
How volatile is NPCE?
NPCE has a Beta of 1.09 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.